Physician profile
Benjamin Paul Chalom Baranes
NPI 1831748532
$931.01
in general payments reported to CMS, 2019-2025
8 companies · $205 in 2025
The $205 reported for 2025 was more than what 76% of General Practice (Dentist) providers received nationally (typical 2025 total: $74.60).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $25.38 · 2022: $123 · 2024: $578 · 2025: $205.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $410 · Gift: $249 · Education: $125.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $409.51 |
| Gift | $248.50 |
| Education | $125.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Straumann USA LLC | $326.17 | 2022-2024 | |
| Meisinger USA, LLC | $239.80 | 2024 | Utb24 |
| Align Technology, INC. | $154.32 | 2025 | Invisalign |
| Dentsply Sirona INC | $66.53 | 2024-2025 | Midwest E Plus, Nupro, Tph Spectra Universal Composite Restorative Low Viscosity |
| Solventum Corporation | $47.00 | 2024-2025 | 3m Espe Filtek Supreme Ultra Universal Restorative, 3m Scotchbond, 3m Relyx |
| 3m Company | $43.22 | 2021-2022 | |
| Orapharma, A Division of Bausch Health US, LLC | $34.91 | 2022-2024 | Ossix Plus, Arestin |
| Zimvie INC. | $19.06 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Baranes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.